Stockscreener 앱 받기
72.73
3.87%
2.71
시간 외 거래:
74.68
1.95
+2.68%
전일 마감가:
$70.02
열려 있는:
$70.02
하루 거래량:
137.50K
Relative Volume:
0.55
시가총액:
$1.27B
수익:
-
순이익/손실:
$-123.28M
주가수익비율:
-24.00
EPS:
-3.03
순현금흐름:
$-111.14M
1주 성능:
+2.39%
1개월 성능:
+12.00%
6개월 성능:
+33.35%
1년 성능:
+6,394%
1일 변동 폭
$69.20
$72.84
1주일 범위
$67.36
$72.84
52주 변동 폭
$0.867
$75.73
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
명칭
Praxis Precision Medicines Inc
전화
617-300-8460
주소
99 HIGH STREET, 30TH FLOOR, BOSTON
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-19 | 개시 | Truist | Buy |
| 2022-06-06 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-12-16 | 개시 | H.C. Wainwright | Buy |
| 2021-08-26 | 개시 | BofA Securities | Buy |
| 2021-04-26 | 개시 | William Blair | Outperform |
| 2020-11-11 | 개시 | Wedbush | Outperform |
| 2020-11-10 | 개시 | Cowen | Outperform |
| 2020-11-10 | 개시 | Evercore ISI | Outperform |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스
Vanguard Group Inc's Strategic Acquisition in Praxis Precision M - GuruFocus.com
Assenagon Asset Management S.A. Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Wednesday - MarketBeat
Praxis Precision Medicines to Announce Third Quarter 2024 - GlobeNewswire
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - StockTitan
(PRAX) Trading Advice - Stock Traders Daily
Moody Aldrich Partners LLC Purchases 7,224 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Praxis Precision To Report Aria Study Data In June - RTTNews
Will Praxis Precision Hit The Targets? - RTTNews
Praxis Precision Medicines revises executive severance terms - Investing.com
Where are the Opportunities in (PRAX) - Stock Traders Daily
Praxis Precision Medicines revises executive severance terms By Investing.com - Investing.com Australia
Praxis Precision To Reveal Key Trial Data On Essential Tremors - RTTNews
Dimensional Fund Advisors LP Sells 8,152 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest - Investing.com India
Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week HighHere's Why - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest By Investing.com - Investing.com South Africa
Praxis stock soars to 52-week high, hits $68 amid robust gains - Investing.com
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Millennium Management LLC - MarketBeat
Praxis Precision Medicines: Great Price Movement, But Still Not Convinced (NASDAQ:PRAX) - Seeking Alpha
Praxis Precision Medicines, Inc (PRAX): A Small-Cap Leader in Biopharmaceuticals - Insider Monkey
The Manufacturers Life Insurance Company Buys 15,443 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines Sees Unusually Large Options Volume (NASDAQ:PRAX) - MarketBeat
10 Small Cap Stocks with High Potential - Insider Monkey
Praxis Precision Medicines (PRAX) Moves 8.4% Higher: Will This Strength Last? - MSN
(PRAX) Investment Analysis and Advice - Stock Traders Daily
PRAX Stock: Exploring Praxis Precision Medicines Inc’s Growth - The InvestChronicle
Praxis stock soars to 52-week high, hits $67.36 amid robust gains By Investing.com - Investing.com South Africa
Praxis stock soars to 52-week high, hits $67.36 amid robust gains - Investing.com Australia
Truist maintains Buy rating on Praxis shares By Investing.com - Investing.com Australia
Noteworthy Thursday Option Activity: PRAX, CVNA, AMPY - Nasdaq
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 2.3% - MarketBeat
Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 3.6% - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Perceptive Advisors LLC - MarketBeat
Marshall Wace LLP Boosts Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Fred Alger Management LLC Has $107,000 Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines presents on ulixacaltamide - GlobeNewswire
Praxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International Congress - StockTitan
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Point72 Asset Management L.P. Grows Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Rhumbline Advisers Grows Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9% - MarketBeat
Ally Bridge Group NY LLC Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Tri Locum Partners LP Sells 31,175 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision’s relutrigine reduces seizures in rare epileptic disorders in phase 2 clinical trials - 2 Minute Medicine
49,510 Shares in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Bought by Bank of New York Mellon Corp - MarketBeat
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 2.5% - MarketBeat
TD Asset Management Inc Increases Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
TD Asset Management Inc Grows Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Praxis Precision Medicines Inc (PRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):